Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de CStone Pharmaceuticals?

Accepted Answer

Según el último estado financiero (Form-10K), CStone Pharmaceuticals tiene un total de activos de $1,393, una ganancia neta loss de $-91

Question 2

¿Cuáles son los ratios financieros clave para CSPHF?

Accepted Answer

El ratio corriente de CStone Pharmaceuticals es 1.35, el margen neto es -22.35, las ventas por acción son $0.31.

Question 3

¿Cómo se desglosan los ingresos de CStone Pharmaceuticals por segmento o geografía?

Accepted Answer

CStone Pharmaceuticals largest revenue segment is Biopharmaceutical Products, at a revenue of 512,544,470 in the most earnings release.For geography, China (excluding Hong Kong and Taiwan) is the primary market for CStone Pharmaceuticals, at a revenue of 409,107,819.

Question 4

¿Es rentable CStone Pharmaceuticals?

Accepted Answer

no, según los últimos estados financieros, CStone Pharmaceuticals tiene una ganancia neta loss de $-91

Question 5

¿Tiene CStone Pharmaceuticals alguna deuda?

Accepted Answer

yes, CStone Pharmaceuticals tiene una deuda de 1,029

Question 6

¿Cuántas acciones en circulación tiene CStone Pharmaceuticals?

Accepted Answer

CStone Pharmaceuticals tiene un total de acciones en circulación de 1,284.23

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	202	407	463	481	243	1,038
Revenue Growth (YoY)	-56%	-12%	-4%	98%	-77%	--
Cost of Revenue	227	167	159	202	106	241
Gross Profit	-24	240	304	278	136	797
Selling, General & Admin	181	211	382	576	661	484
Research & Development	162	123	501	590	1,304	1,404
Operating Expenses	329	322	857	1,158	1,930	1,859
Other Non Operating Income (Expenses)	--	-3	-1	--	--	--
Pretax Income	-377	-91	-367	-902	-1,920	-1,220
Income Tax Expense	--	--	--	--	--	--
Net Income	-377	-91	-367	-902	-1,920	-1,220
Net Income Growth	165%	-75%	-59%	-53%	56.99%	-41%
Shares Outstanding (Diluted)	1,314.13	1,276.19	1,263.07	1,172.83	1,165.2	1,046.03
Shares Change (YoY)	3%	1%	8%	1%	11%	21%
EPS (Diluted)	-0.28	-0.07	-0.29	-0.76	-1.64	-1.16
EPS Growth	159%	-75%	-62%	-53%	41%	-51%
Free Cash Flow	-430	-343	-653	-714	-1,633	-579
Free Cash Flow Per Share	-0.32	-0.26	-0.51	-0.6	-1.4	-0.55
Gross Margin	-11.88%	58.96%	65.65%	57.79%	55.96%	76.78%
Operating Margin	-175.24%	-19.9%	-119.43%	-182.95%	-737.86%	-102.31%
Profit Margin	-186.63%	-22.35%	-79.26%	-187.52%	-790.12%	-117.53%
Free Cash Flow Margin	-212.87%	-84.27%	-141.03%	-148.44%	-672.01%	-55.78%
EBITDA	--	-32	-495	-836	-1,771	-1,048
EBITDA Margin	--	-7.86%	-106.91%	-173.8%	-728.8%	-100.96%
D&A For EBITDA	--	49	58	44	22	14
EBIT	-354	-81	-553	-880	-1,793	-1,062
EBIT Margin	-175.24%	-19.9%	-119.43%	-182.95%	-737.86%	-102.31%
Effective Tax Rate	--	--	--	--	--	--

CStone Pharmaceuticals (CSPHF) Price

CSPHF Stock Price Chart

CSPHF Income

Follow-Up Questions